BDMD
Baird Medical Investment Holdings Limited
Medical - Devices
Market Cap$68M
5Y Perf.-81.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
BDMD vs HLIT
Revenue, margins, valuation, and 5-year total return — side by side.
HLIT
Harmonic Inc.
Communication Equipment
Market Cap$1.38B
5Y Perf.+4.4%
BDMD vs HLIT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | BDMD | HLIT |
|---|---|---|
| Industry | Medical - Devices | Communication Equipment |
| Market Cap | $68M | $1.38B |
| Revenue (TTM) | $37M | $636M |
| Net Income (TTM) | $12M | $50M |
| Gross Margin | 88.2% | 55.7% |
| Operating Margin | 41.4% | 12.1% |
| Forward P/E | 3.8x | 21.8x |
| Total Debt | $21M | $148M |
| Cash & Equiv. | $3M | $101M |
BDMD vs HLIT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
BDMD
HLIT
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| Baird Medical Inves… (BDMD) | 100 | 18.9 | -81.1% |
| Harmonic Inc. (HLIT) | 100 | 104.4 | +4.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BDMD vs HLIT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: BDMD leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Harmonic Inc. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
BDMD
Baird Medical Investment Holdings Limited
The Income Pick
BDMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 1.15
- Rev growth 17.7%, EPS growth 19.5%, 3Y rev CAGR 10.1%
- Lower volatility, beta 1.15, Low D/E 52.5%, current ratio 1.77x
Best for: income & stability and growth exposure
HLIT
Harmonic Inc.
The Long-Run Compounder
HLIT is the clearest fit if your priority is long-term compounding.
- 269.9% 10Y total return vs BDMD's -80.8%
- +38.1% vs BDMD's -65.2%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | BDMD | 17.7% revenue growth vs HLIT's 11.6% |
| Value | BDMD | Lower P/E (3.8x vs 21.8x) |
| Quality / Margins | BDMD | 33.6% margin vs HLIT's 7.8% |
| Stability / Safety | BDMD | Beta 1.15 vs HLIT's 1.51 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | HLIT | +38.1% vs BDMD's -65.2% |
| Efficiency (ROA) | BDMD | 18.5% ROA vs HLIT's 6.5%, ROIC 22.6% vs 9.3% |
BDMD vs HLIT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2024
BDMD vs HLIT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLBDMDLAGGINGHLIT
HLITHarmonic Inc.
1leads
BDMDBaird Medical Investm…
3leads
6 Total Categories
CATEGORYLEADERvs HLITMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
BDMD3/4
Valuation MetricsMultiples, price ratios, and targets
BDMD4/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
BDMD7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
HLIT5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
BDMD leads this category, winning 3 of 4 comparable metrics.
Income & Cash Flow (Last 12 Months)
HLIT is the larger business by revenue, generating $636M annually — 17.2x BDMD's $37M. BDMD is the more profitable business, keeping 33.6% of every revenue dollar as net income compared to HLIT's 7.8%.
| Metric | BDMDBaird Medical Inv… | HLITHarmonic Inc. |
|---|---|---|
| RevenueTrailing 12 months | $37M | $636M |
| EBITDAEarnings before interest/tax | — | $88M |
| Net IncomeAfter-tax profit | — | $50M |
| Free Cash FlowCash after capex | — | $133M |
| Gross MarginGross profit ÷ Revenue | +88.2% | +55.7% |
| Operating MarginEBIT ÷ Revenue | +41.4% | +12.1% |
| Net MarginNet income ÷ Revenue | +33.6% | +7.8% |
| FCF MarginFCF ÷ Revenue | -24.8% | +21.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -27.3% |
| EPS Growth (YoY)Latest quarter vs prior year | — | -87.5% |
BDMD leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
BDMD leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 3.8x trailing earnings, BDMD trades at a 90% valuation discount to HLIT's 37.2x P/E. On an enterprise value basis, BDMD's 5.1x EV/EBITDA is more attractive than HLIT's 18.9x.
| Metric | BDMDBaird Medical Inv… | HLITHarmonic Inc. |
|---|---|---|
| Market CapShares × price | $68M | $1.4B |
| Enterprise ValueMkt cap + debt − cash | $86M | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | 3.80x | 37.21x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 21.80x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 5.13x | 18.93x |
| Price / SalesMarket cap ÷ Revenue | 1.84x | 2.03x |
| Price / BookPrice ÷ Book value/share | 1.20x | 3.10x |
| Price / FCFMarket cap ÷ FCF | — | 26.13x |
BDMD leads this category, winning 4 of 4 comparable metrics.
Profitability & Efficiency
BDMD leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
BDMD delivers a 33.0% return on equity — every $100 of shareholder capital generates $33 in annual profit, vs $11 for HLIT. HLIT carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to BDMD's 0.53x. On the Piotroski fundamental quality scale (0–9), HLIT scores 7/9 vs BDMD's 2/9, reflecting strong financial health.
| Metric | BDMDBaird Medical Inv… | HLITHarmonic Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +33.0% | +11.2% |
| ROA (TTM)Return on assets | +18.5% | +6.5% |
| ROICReturn on invested capital | +22.6% | +9.3% |
| ROCEReturn on capital employed | +37.8% | +11.2% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 |
| Debt / EquityFinancial leverage | 0.53x | 0.32x |
| Net DebtTotal debt minus cash | $18M | $47M |
| Cash & Equiv.Liquid assets | $3M | $101M |
| Total DebtShort + long-term debt | $21M | $148M |
| Interest CoverageEBIT ÷ Interest expense | 26.55x | 12.92x |
BDMD leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
HLIT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLIT five years ago would be worth $16,938 today (with dividends reinvested), compared to $1,923 for BDMD. Over the past 12 months, HLIT leads with a +38.1% total return vs BDMD's -65.2%. The 3-year compound annual growth rate (CAGR) favors HLIT at -3.1% vs BDMD's -43.4% — a key indicator of consistent wealth creation.
| Metric | BDMDBaird Medical Inv… | HLITHarmonic Inc. |
|---|---|---|
| YTD ReturnYear-to-date | +38.8% | +22.6% |
| 1-Year ReturnPast 12 months | -65.2% | +38.1% |
| 3-Year ReturnCumulative with dividends | -81.9% | -8.9% |
| 5-Year ReturnCumulative with dividends | -80.8% | +69.4% |
| 10-Year ReturnCumulative with dividends | -80.8% | +269.9% |
| CAGR (3Y)Annualised 3-year return | -43.4% | -3.1% |
HLIT leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — BDMD and HLIT each lead in 1 of 2 comparable metrics.
Risk & Volatility
BDMD is the less volatile stock with a 1.15 beta — it tends to amplify market swings less than HLIT's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HLIT currently trades 99.2% from its 52-week high vs BDMD's 25.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | BDMDBaird Medical Inv… | HLITHarmonic Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.15x | 1.51x |
| 52-Week HighHighest price in past year | $7.26 | $12.38 |
| 52-Week LowLowest price in past year | $0.76 | $7.80 |
| % of 52W HighCurrent price vs 52-week peak | +25.6% | +99.2% |
| RSI (14)Momentum oscillator 0–100 | 47.5 | 76.9 |
| Avg Volume (50D)Average daily shares traded | 960K | 1.1M |
Evenly matched — BDMD and HLIT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | BDMDBaird Medical Inv… | HLITHarmonic Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $12.50 |
| # AnalystsCovering analysts | — | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.2% |
Insufficient data to determine a leader in this category.
Key Takeaway
BDMD leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HLIT leads in 1 (Total Returns). 1 tied.
Best OverallBaird Medical Investment Ho… (BDMD)Leads 3 of 6 categories
Loading custom metrics...
BDMD vs HLIT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is BDMD or HLIT a better buy right now?
For growth investors, Baird Medical Investment Holdings Limited (BDMD) is the stronger pick with 17.
7% revenue growth year-over-year, versus 11. 6% for Harmonic Inc. (HLIT). Baird Medical Investment Holdings Limited (BDMD) offers the better valuation at 3. 8x trailing P/E, making it the more compelling value choice. Analysts rate Harmonic Inc. (HLIT) a "Hold" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BDMD or HLIT?
On trailing P/E, Baird Medical Investment Holdings Limited (BDMD) is the cheapest at 3.
8x versus Harmonic Inc. at 37. 2x.
03Which is the better long-term investment — BDMD or HLIT?
Over the past 5 years, Harmonic Inc.
(HLIT) delivered a total return of +69. 4%, compared to -80. 8% for Baird Medical Investment Holdings Limited (BDMD). Over 10 years, the gap is even starker: HLIT returned +269. 9% versus BDMD's -80. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BDMD or HLIT?
By beta (market sensitivity over 5 years), Baird Medical Investment Holdings Limited (BDMD) is the lower-risk stock at 1.
15β versus Harmonic Inc. 's 1. 51β — meaning HLIT is approximately 31% more volatile than BDMD relative to the S&P 500. On balance sheet safety, Harmonic Inc. (HLIT) carries a lower debt/equity ratio of 32% versus 53% for Baird Medical Investment Holdings Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — BDMD or HLIT?
By revenue growth (latest reported year), Baird Medical Investment Holdings Limited (BDMD) is pulling ahead at 17.
7% versus 11. 6% for Harmonic Inc. (HLIT). On earnings-per-share growth, the picture is similar: Baird Medical Investment Holdings Limited grew EPS 19. 5% year-over-year, compared to -54. 2% for Harmonic Inc.. Over a 3-year CAGR, HLIT leads at 10. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BDMD or HLIT?
Baird Medical Investment Holdings Limited (BDMD) is the more profitable company, earning 33.
6% net margin versus 5. 8% for Harmonic Inc. — meaning it keeps 33. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BDMD leads at 41. 4% versus 9. 3% for HLIT. At the gross margin level — before operating expenses — BDMD leads at 88. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — BDMD or HLIT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is BDMD or HLIT better for a retirement portfolio?
For long-horizon retirement investors, Baird Medical Investment Holdings Limited (BDMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
15)). Harmonic Inc. (HLIT) carries a higher beta of 1. 51 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BDMD: -80. 8%, HLIT: +269. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between BDMD and HLIT?
These companies operate in different sectors (BDMD (Healthcare) and HLIT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BDMD is a small-cap high-growth stock; HLIT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(BDMD: 17.7% · HLIT: -27.3%)Net Margin>
%
(BDMD: 33.6% · HLIT: 7.8%)P/E Ratio<
x
(BDMD: 3.8x · HLIT: 37.2x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.